Association Between qEEG Measure and Post-Operative Cognitive Dysfunction (POCD) and Postoperative Delirium (POD)

NCT ID: NCT03977350

Last Updated: 2020-09-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

50 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-09-23

Study Completion Date

2022-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Cognitive complications after major surgery are a common phenomenon. The incidence of Postoperative Cognitive Dysfunction (POCD), may vary from 5% to 25% in adult patients, depending on different risk factors. Age has been strongly associated with cognitive complications. POCD is a prolonged decline in cognitive function that appears after surgery as compared with preoperative functions. In order to classify evaluate POCD, it requires at least 2 measurements. A baseline, completed before surgery and a second measurement, post surgery.

In light of the high prevalence of POCD and the difficulties in its prediction, NeuroIndex has developed a quantitative EEG system and software that aim to produces risk predictor index (IS) for POCD. This study aims to evaluate the relationship between the software produced predictor index and the actual POCD events. The qEEG will be monitored during the surgery in addition to the routine clinical practice in operating rooms.

POCD will be evaluated using Montreal Cognitive Assessment test (MoCA) prior and post surgery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cognitive Dysfunction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients over 65 years undergoing heart surgery

Patients over 65 years undergoing heart surgery under anesthesia, EEG monitored

EEG monitoring

Intervention Type DEVICE

EEG monitoring under general anesthesia

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

EEG monitoring

EEG monitoring under general anesthesia

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Males and females between the ages of 65 or above.
* Subjects with American Society of Anesthesiologists physical status I-III.
* Subjects who are intended to undergo cardiac surgery (CABG or valve replacement) under general anesthesia.
* Surgical procedures scheduled for over 30 minutes.
* Lack of significant hearing disturbances.
* Subjects with ability to read and understand the consent form.

Exclusion Criteria

* Significant visual impairment so that the pictures of the confusion assessment method could not be interpreted to accurately test to assess delirium.
* Profound dementia or aphasia that interfered with the assessment of cognitive dysfunction (positive delirium in CAM-ICU).
* Patients with a history of stroke.
* Any documented major neurologic or psychiatric dysfunction.
* Pregnant women.
* Long term use of sedative-hypnotic drugs and antidepressant drug.
* Subjects with scalp or skull abnormalities (s/p brain surgery, cranial implants).
Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Neuroindex Ltd.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Dror Leviner, Dr.

Role: PRINCIPAL_INVESTIGATOR

Carmel Medical Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Carmel Medical Center

Haifa, , Israel

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Israel

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Ester Pri-Or, Nurse CRA

Role: CONTACT

972-506629699

Tamar A Arens, Dr.

Role: CONTACT

972543532120

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Erez Sharoni, Dr

Role: primary

972-4-8250621

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CLD5

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.